TheBody.com/TheBodyPRO.com cover the 17th Conference on Retroviruses and Opportunistic Infections (CROI 2010)

BROWSE CROI 2010 COVERAGE

CROI 2010 Newsroom

Conference Coverage at TheBody.com | CROI 2010 Web Highlights

Conference Coverage at TheBody.com

CROI 2010 Wrap-Up: Complications of HIV and Its Treatment (March 30, 2010)
A discussion with Pablo Tebas, M.D.
In The 17th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
Future of AIDS Gels May Lie in Drugs, Experts Say (March 8, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
CROI 2010 Wrap-Up: The Evolution of Antiretroviral Therapy (March 8, 2010)
A discussion with Joel Gallant, M.D., M.P.H.
In The 17th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
CROI 2010 Wrap-Up: The HIV Drug Development Pipeline (March 8, 2010)
A discussion with Joel Gallant, M.D., M.P.H.
In The 17th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
HIV Vaccine Trial Lessons: What Researchers Learned From the STEP Study's Failure and the RV144 ("Thai") Study's Success (March 3, 2010)
A discussion with Nelson Michael, M.D., Ph.D., and Morgane Rolland, Ph.D.
In The 17th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
Shorter Duration of TB-Prevention Therapy Including Ethambutol May Be Effective, Study Suggests (March 3, 2010)
A discussion with Soumya Swaminathan, M.D.
In The 17th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
HCV Survival in Syringes Affected by Syringe Type, Time and Temperature (March 3, 2010)
A discussion with Elijah Paintsil, M.D., F.A.A.P.
In The 17th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
Community Benefits of "Test and Treat" (Winter/Spring 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
On TheBodyPRO.com
ART Lowers Heterosexual Transmission Risk (Winter/Spring 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
PRO 2000 Microbicide Proves Ineffective (Winter/Spring 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Thai Vaccine Trial Shows Minimal Benefit (Winter/Spring 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
On TheBodyPRO.com
Smoking Cessation Lowers Cardiovascular Risk (Winter/Spring 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
On TheBodyPRO.com
Gains in Life Expectancy (Winter/Spring 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
On TheBodyPRO.com
Vicriviroc Faces Further Challenges (Winter/Spring 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Good Results for New Booster and Quad Pill (Winter/Spring 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Vitamin D Deficiency (Winter/Spring 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Smoking Cessation Reduces CVD Risk in HIV (March 1, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
Why There's Such an HIV/AIDS Disparity Among U.S. Blacks and Hispanics -- and What to Do About It (February 24, 2010)
A discussion with Kimberly Smith, M.D., M.P.H.
In The 17th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
HIV Does Not Worsen H1N1-Related Complications (and Vice Versa), Study Finds (February 24, 2010)
A discussion with Esteban Martinez, M.D.
In The 17th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
News Outlets Examine Use of ART, Microbicide Development Presented at Conference (February 22, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
The Once and Future King: What Will Replace Atripla Atop the First-Line HIV Treatment Realm? (Feb. 19, 2010; 3:39 p.m. Pacific Time)
A blog entry from CROI 2010 by Gerald Pierone Jr., M.D.
In The 17th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
HIV Independently, but Modestly, Increases Risk of Fragility Fractures, Study of U.S. Male Veterans Finds (February 19, 2010)
A discussion with Julie Womack, Ph.D.
In The 17th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
Detachable Needles on Syringes Promote Hepatitis C Transmission, Study Says (February 19, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
U.S. Company Virxsys Says Using AIDS to Fight AIDS (February 19, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
AIDS Vaccine Effects May Wear Off, Researchers Say (February 19, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
Whatever Happened to H1N1 (Swine Flu) and HIV? New Answers at CROI 2010 (Feb. 19, 2010; 10:15 a.m. Pacific Time)
A blog entry from CROI 2010 by Anjali Sanghvi.
In The 17th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
News Outlets Examine HIV Vaccine Research, Cervical Cancer Screening Data Presented at Conference (February 19, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
On TheBodyPRO.com
Blog: Goosby Reflects on U.S. Response to Global HIV/AIDS at CROI (February 19, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
ACTG 5202 Substudy Finds Little Lipoatrophy but Signs of Bone Loss Across the Board; Devil Is in the Details (February 19, 2010)
A discussion with Grace McComsey, M.D.
In The 17th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
HIV Drugs Prevent Infection in African Study (February 18, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
The End of HIV Drug Development as We Know It? (Feb. 18, 2010; 1:45 p.m. Pacific Time)
A blog entry from CROI 2010 by Gerald Pierone Jr., M.D.
In The 17th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
Studies Show Long-Term Couples Overlooked by HIV Prevention Strategies (February 18, 2010)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
The New Quad on the Block: Gilead's Four-Drug, Fixed-Dose Combination With a Novel Booster Sails Through Phase 2 Trials (Feb. 18, 2010; 1:15 a.m. Pacific Time)
A blog entry from CROI 2010 by Myles Helfand.
In The 17th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
Why Vicriviroc Failed in Its Phase 3 Trials -- and What It May Mean for Future Studies in HIV Treatment-Experienced People (Feb. 17, 2010; 11:36 a.m. Pacific Time)
A blog entry from CROI 2010 by Myles Helfand.
In The 17th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
HIV/AIDS Research Should Focus More Heavily on Ending the Pandemic, NIAID Director Says (February 17, 2010)
A discussion with Anthony Fauci, M.D.
In The 17th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com
Will CROI 2010 Provide HIV/AIDS Clinicians With More Questions Than Answers? (Feb. 16, 2010; 4:49 p.m. Pacific Time)
A blog entry from CROI 2010 by Myles Helfand.
In The 17th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO.com

CROI 2010 Web Highlights

Bone and Limb Fat Outcomes in ACTG5202 -- More Bone Loss With TDF/FTC Than ABC/3TC (February 23, 2010)
From National AIDS Treatment Advocacy Project
ART Improves Cerebral Blood Flow -- but Not to Levels in HIV-Negatives (February 23, 2010)
From National AIDS Treatment Advocacy Project
Progression of Atherosclerosis Is Linked to Inflammation in People With HIV (February 23, 2010)
From aidsmap.com
HIV Infection Increases Risk of Bone Fractures for Men, but Not for Younger Women (February 23, 2010)
From aidsmap.com
Mixed Findings on Value of Brain-Penetrating Antiretroviral Scores (February 22, 2010)
From National AIDS Treatment Advocacy Project
Successful Hepatitis C Treatment Reduces HIV Disease Progression and Non-Liver-Related Mortality (February 22, 2010)
From aidsmap.com
Triglycerides Linked to Heart Attack Risk in D:A:D Study (February 22, 2010)
From aidsmap.com
Many Patients Diagnosed With HIV Today Will Have Normal Life Expectancies, European Studies Find (February 22, 2010)
From aidsmap.com
Heart Risk Factors Tied to Neurocognitive Skills in SMART Substudy (February 21, 2010)
From National AIDS Treatment Advocacy Project
T-Cell Activation and Senescence Linked to Carotid Lesions in HIV-Positive Women (February 21, 2010)
From National AIDS Treatment Advocacy Project
Antiretroviral Drugs Have Variable Effects on Bones and Fat, Lipoatrophy Uncommon With Modern Regimens (February 21, 2010)
From aidsmap.com
EuroSIDA Study Suggests Tenofovir Increases Risk of Chronic Kidney Disease (February 21, 2010)
From aidsmap.com
Studies Confirm That Drugs That Penetrate Brain Control HIV Better and Improve Symptoms of Brain Impairment (February 21, 2010)
From aidsmap.com
Heart Risk Falls With Time Since Quitting Smoking in D:A:D (February 20, 2010)
From National AIDS Treatment Advocacy Project
Fast ART in Late Disease Means Slower Progression in Europe and Canada (February 20, 2010)
From National AIDS Treatment Advocacy Project
Chronic HIV and HCV Swell Stroke Risk in Veterans Aging Cohort (February 20, 2010)
From National AIDS Treatment Advocacy Project
Life Expectancy Approaches Normal in Dutch Without HIV Symptoms (February 20, 2010)
From National AIDS Treatment Advocacy Project
Three Years With More Than 500 CD4s Normalizes Mortality in HIV-Positive Men (February 20, 2010)
From National AIDS Treatment Advocacy Project
High Triglycerides Independently Raise MI Risk in D:A:D Study (February 20, 2010)
From National AIDS Treatment Advocacy Project
Chemotherapy Plus ART Best Treatment for Kaposi's Sarcoma in South African Study (February 20, 2010)
From aidsmap.com
Hepatitis C Virus Can Survive in Syringes for Up to 63 Days (February 20, 2010)
From aidsmap.com
Most Non-AIDS Cancers Not Diagnosed at Earlier Age in People With AIDS (February 19, 2010)
From National AIDS Treatment Advocacy Project
HIV Load Tied to Fibrosis Signal in Women Without Hepatitis or Alcohol Abuse (February 19, 2010)
From National AIDS Treatment Advocacy Project
Antiretroviral Risk Factors for Kidney Disease in EuroSIDA: Tenofovir Is Not Alone (February 19, 2010)
From National AIDS Treatment Advocacy Project
Inflammation Tied to Endothelial Dysfunction Despite Tight HIV Control (February 19, 2010)
From National AIDS Treatment Advocacy Project
Inflammation and Fibrosis Markers Tied to AIDS or Death After Good Virologic Response (February 19, 2010)
From National AIDS Treatment Advocacy Project
HIV Treatment May Prevent at Least Nine Out of Ten Transmissions (February 19, 2010)
From aidsmap.com
Vitamin D Deficiency Extremely Common Among HIV-Positive Patients in Diverse Regions (February 19, 2010)
From aidsmap.com
One-Quarter Died on HIV Treatment Waiting List in South Africa's Free State Province (February 19, 2010)
From aidsmap.com
Immune Restoration in DART Study: Late Start Means Low CD4 Count for Years (February 19, 2010)
From aidsmap.com
Treatment Drive in British Columbia Produces Modest Declines in Diagnoses and Viral Loads (February 19, 2010)
From aidsmap.com
Smoking Cessation Lowers Cardiovascular Risk in D:A:D Cohort (February 19, 2010)
From aidsmap.com
Maraviroc Showing Tantalising Promise as Microbicide in Preclinical Studies (February 19, 2010)
From aidsmap.com
More Evidence Supports Isoniazid for TB Prevention in People With HIV (February 19, 2010)
From aidsmap.com
RNA Spikes Predict Heart Disease, CD4s Predict Liver and Kidney Disease (February 18, 2010)
From National AIDS Treatment Advocacy Project
Side Effect and CD4 Differences in Four ACTG 5202 Arms at 96 Weeks (February 18, 2010)
From National AIDS Treatment Advocacy Project
Low-Level Viremia Quadruples Death Risk in Canadian Cohort Study (February 18, 2010)
From National AIDS Treatment Advocacy Project
High Rate of Coronary Artery Problems in Young People Tied to TDF/FTC (February 18, 2010)
From National AIDS Treatment Advocacy Project
Older Age, Lower CD4 Nadir, NNRTI Use Predict Slow CD4 Recovery in ATHENA (February 18, 2010)
From National AIDS Treatment Advocacy Project
Vicriviroc Does Not Outdo Placebo Regimen in Phase 3 Trials (February 18, 2010)
From National AIDS Treatment Advocacy Project
Maraviroc Does Not Boost Stalled CD4s in Virologically Suppressed People (February 18, 2010)
From National AIDS Treatment Advocacy Project
QUAD Four-in-One Pill as Strong as Atripla, but a Kidney Concern Arises (February 18, 2010)
From National AIDS Treatment Advocacy Project
Elvitegravir "Quad" Pill Performs Well, New Booster Cobicistat Works as Well as Ritonavir (February 18, 2010)
From aidsmap.com
New CCR5 Antagonist TBR-652 Shows Good Antiviral Activity in Early Study (February 18, 2010)
From aidsmap.com
CCR5 Antagonist Vicriviroc Fails to Surpass Potent Background Regimen (February 18, 2010)
From aidsmap.com
Once-Daily Darunavir Effective and Less Toxic Than Twice-Daily in Experienced Patients Without Prior Darunavir Resistance: ODIN (February 18, 2010)
From aidsmap.com
French Gay Men Face Sixtyfold HIV Risk: Incidence Increasing in Netherlands (February 18, 2010)
From aidsmap.com
Increased Testing Leads to Decrease in Viral Load and Infections in San Francisco, and in Late Diagnosis in Washington (February 18, 2010)
From aidsmap.com
ACTG 5202: No Significant Difference in Time to Failure Between Kivexa and Truvada in Patients With Lower Viral Loads When Paired With Efavirenz or Atazanavir (February 18, 2010)
From aidsmap.com
Overall HIV Prevalence Stabilises at 11% in South Africa, With Decreases in Younger Age Groups (February 18, 2010)
From aidsmap.com
Risk Factors for Lung Cancer in People With HIV: Smoking Vastly Outweighs HIV (February 17, 2010)
From aidsmap.com
Preventing Cervical Cancer: Good Outcomes From Screening Program for HIV-Positive Zambian Women (February 17, 2010)
From aidsmap.com
Goosby Warns of Need for Long-Term Funding Commitment for AIDS, Says Financial Trades Tax Is "Interesting" (February 17, 2010)
From aidsmap.com
17th Conference on Retroviruses and Opportunistic Infections
Official conference Web site.

The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.